On Jun. 21, 2022, Anixa Biosciences announced the publication of a peer-reviewed journal article in Clinical and Experimental…
On Jan. 19, 2022, South African-born U.S. biotech billionaire Patrick Soon-Shiong launched a vaccine manufacturing plant in the…
On Jun. 17, 2022, the U.S. Food and Drug Administration (FDA) authorized emergency use of the Moderna COVID-19…
On Jun. 17, 2022, Pfizer and BioNTech announced the U.S. Food and Drug Administration (FDA) had granted emergency…
On Jun. 15, 2022, Pfizer and BioNTech announced the European Medicines Agency (EMA) had initiated a rolling review…
On Jun. 14 2022, Oragenics announced the publication of an article co-authored by Oragenics and collaborators at Inspirevax…
On Jun. 13 2022, Novavax announced that the Australian Therapeutic Goods Administration (TGA) had granted provisional registration of…
On Jun. 8, 2022, Moderna announced new clinical data on its Omicron-containing bivalent COVID booster candidate, mRNA-1273.214, containing…
On Jun. 2, 2022, Novavax announced the submission of a request to the Medicines and Healthcare products Regulatory…
On Jun. 2, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service confirmed the…
On Jun. 2, 2022, The European Commission and the vaccine developer Moderna announced they have reached an agreement…
On May 31, 2022, Novavax announced the initiation of its Phase 3 strain change trial to determine if…
On May 31, 2022, Moderna and Takeda announced the transfer of the marketing authorization for Moderna’s COVID-19 vaccine…
On May 30, 2022, The Centre for Health Protection (CHP) of the Department of Health received notification from…
On May 25, 2022, Pfizer and BioNTech announced topline safety, immunogenicity and vaccine efficacy data from a Phase…
On May 25, 2022, Roche and its subsidiary TIB Molbiol announced they had developed three unique LightMix Modular…
On May 25, 2022, Novavax announced it was participating in a stage of the COVID-19 Vaccine Schedule Combinations…
On May 21, 2022, the World Health Organization (WHO) announced that since May 13, 2022, cases of mpox…
On May 20, 2022, Novavax announced the submission of a request to the European Medicines Agency (EMA) to…
On May 19, 2022, World Health Organization (WHO) issued an emergency use listing (EUL) for CONVIDECIA, a vaccine…
On May 18, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On May 18, 2022, scientists at the Centers for Disease Control and Prevention (CDC) announced that they were…
On May 18, 2022, researchers at Gladstone Institutes and UC San Francisco (UCSF) reported that unvaccinated people, infection…
On May 18, 2022, Moderna and the nonprofit scientific research organization IAVI announced that the first participant screenings…
On May 17, 2022, Pfizer and BioNTech announced the U.S. Food and Drug Administration expanded emergency use authorization…
On May 13, 2022, Novavax announced the submission of a request for emergency use authorization to Taiwan’s Food…
On May 12, 2022, the World Health Organization (WHO) COVID-19 Technology Access Pool and the Medicines Patent Pool…
On May 6, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had launched…
On May 6, 2022, Novavax announced that deliveries of it’s COVID-19 vaccine continued around the world and the…
On May 6, 2022, Novavax announced the submission of variations to the Australian Therapeutic Goods Agency (TGA) and…